Ajay Pandita
Ajay Pandita is a biotech and diagnostics executive with over 20 years of leadership in precision medicine, multiomic innovation, and translational oncology. He currently serves as Vice President of Scientific Affairs at 1Cell.Ai, where he drives scientific strategy, clinical development, and biopharma partnerships to advance Cell Biopsy powered by OncoIncytes. This next-generation platform integrates single-cell DNA, RNA, and protein profiling from blood to enable real-time insights into tumor biology for drug development and biomarker discovery.
Previously, Ajay led the operational development of a liquid biopsy platform at CellMax Life and helped scale Core Diagnostics into a leading pathology and biomarker-driven CRO, contributing to its successful acquisition. He also played a key role in early biomarker strategy efforts at Genentech and conducted postdoctoral research in cancer genomics at the Mayo Clinic.
Ajay holds a DVM and Ph.D. in Molecular and Cellular Biology, and he received the Children’s Tumor Foundation Young Investigator Award for his research at the Brain Tumor Research Centre. His work bridges scientific innovation with commercial execution, delivering multiomic, real-time insights to advance precision oncology.